The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors^*

References

• Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405–18
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333–40
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465–75
   PubMed Web of Science ®Google Scholar
• Solnek BL, Seiter T. How to diagnose and treat depression. Nurse Pract 2002;27:12–23
   PubMedGoogle Scholar
• Depression. What is depression? The World Health Organization, 2004. Available from http://www.who.int/mental_health/management/depression/definition/en/index.%20html [Last accessed 29 July 2004]
   Google Scholar
• Tan JY, Levin GM. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy 1999;19:675–89
   PubMed Web of Science ®Google Scholar
• Mason J, Freemantle N, Eccles M. Fatal toxicity associated with antidepressant use in primary care. Br J Gen Prac 2000;50: 366–70
   Google Scholar
• Nelson JC. Safety and tolerability of the new antidepressants. J Clin Psychiatry 1997;58(Suppl 6):26–31
   PubMed Web of Science ®Google Scholar
• Simon GE, VonKorff M, Heiligenstein JH, et al. Initial anti-depressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897–902
   PubMed Web of Science ®Google Scholar
• Panzarino PJ Jr, Nash DB. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Am J Manag Care 2001;7:173–84
   PubMed Web of Science ®Google Scholar
• Crown WH. Economic outcomes associated with tricyclic anti-depressant and selective serotonin reuptake inhibitor treatments for depression. Acta Psychiatr Scand Suppl 2000;403:62–6
   PubMedGoogle Scholar
• Crown WH, Hylan TR, Meneades L. Antidepressant selection and use and healthcare expenditures. An empirical approach. Pharmacoeconomics 1998;13:435–48
   Google Scholar
• Baker CB, Johnsrud MT, Crismon ML, et al. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003;183:498–506
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002;287:203–9
   PubMed Web of Science ®Google Scholar
• Strothers HS 3rd, Rust G, Minor P, et al. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc 2005;53:456–61
   Google Scholar
• Melfi CA, Croghan TW, Hanna MP, et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 2000;61:16–21
   PubMed Web of Science ®Google Scholar
• Blazer DG, Hybels GF, Simonsick EM, et al. Marked differences in antidepressant use by race in an elderly community sample: 1986–1996. Am J Psychiatry 2000;157:1089–94
   PubMed Web of Science ®Google Scholar
• Sleath B, Shih YC. Sociological influences on antidepressant prescribing. Soc Sci Med 2003;56:1335–44
   PubMed Web of Science ®Google Scholar
• Sleath BL, Rubin RH, Huston SA. Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother 2001;35:419–23
   Google Scholar
• Kelly YJ, Watt RG, Nazroo JY. Racial/ethnic differences in breastfeeding initiation and continuation in the United Kingdom and comparison with findings in the United States. Pediatrics 2006;118:1428–35
   Google Scholar
• Doyle JJ, Gasciano J, Arikian S, et al. A multinational pharmaco-economic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs, and TCAs. Value Health 2001:4:16–31
   PubMedGoogle Scholar
• Medical Expenditure Panel Survey. Agency for Healthcare Research and Quality, 2006. Available from http://www.meps.ahrq.gov/ [Last accessed 16 June 2006]
   Google Scholar
• Lexicon. Cerner Multum, Inc., 2006. Available from http://www.multum.com/Lexicon.htm [Last accessed 6 March 2006]
   Google Scholar
• Greene WH. Econometric Analysis. 4th edn. Upper Saddle River, NJ: Prentice Hall, 2000
   Google Scholar
• Andersen RM, Davidson P. Improving access to care in America: Individual and contextual indicators. In: Anderson RM, Rice TH, Kominski GF, editors. Changing the U.S. health care system: key issues in health services policy and management. San Francisco, CA: Joss-Bailey, 2001, pp.3–30
   Google Scholar
• Craig BM. Econometric models of expenditure. ISPOR Educational Teleconference, 28 October, 2005. Available from http://www.ispor.org/student/teleconferences/Craig-Slides.pdf [Last accessed 2 March 2007]
   Google Scholar
• Chen AY, Chang R-KY. Factors associated with prescription drug expenditures among children: an analysis of the Medical Expenditure Panel Survey. Pediatrics 2002;109:728–32
   Google Scholar
• Daumit GL, Crum RM, Guallar E, et al. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Arch Gen Psychiatry 2003;60: 121–8
   PubMed Web of Science ®Google Scholar
• Smith SR, Kirking DM. Access and use of medications in HIV disease. Health Serv Res 1999;34:123–44
   PubMed Web of Science ®Google Scholar
• Wang J, Noel JM, Zuckerman IH, et al. Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Med Care Res Rev 2006;63:742–63
   PubMed Web of Science ®Google Scholar
• Wang J, Zuckerman IH, Miller NA, et al. Utilizing new prescription drugs: racial and ethnic disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res 2007 [in press]
   Google Scholar
• Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995;9(Suppl 4):33–40
   PubMed Web of Science ®Google Scholar
• Guze BH. Selective serotonin reuptake inhibitors. Assessment for formulary inclusion. Pharmacoeconomics 1996;9:430–42
   PubMed Web of Science ®Google Scholar
• LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and White cardiac patients. Med Care Res Rev 2000;57(Suppl 1):146–61
   Google Scholar
• Mayberry RM, Mili F, Ofili E. Racial and ethnic differences in access to medical care. Med Care Res Rev 2000;57 (Suppl 1):108–45
   PubMed Web of Science ®Google Scholar
• Morrison RS, Wallenstein S, Natale DK, et al. ‘We don’t carry that’ – failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. New Engl J Med 2000;342:1023–6
   PubMed Web of Science ®Google Scholar
• Spernak SM, Mintz M, Paulson J, et al. Neighborhood racial composition and availability of asthma drugs in retail pharmacies. J Asthma 2005;42:731–5
   PubMed Web of Science ®Google Scholar
• Stolley P. Race in epidemiology. Int J Health Serv 1999;29:905–9
   PubMed Web of Science ®Google Scholar
• Jones CP. Invited commentary: ‘race,’ racism, and the practice of epidemiology. Am J Epidemiol 2001;154:299–304
   PubMed Web of Science ®Google Scholar
• Jones CP. Levels of racism: a theoretic framework and a gardener’s tale. Am J Public Health 2000;90:1212–5
   PubMed Web of Science ®Google Scholar
• Sclar DA, Robison LM, Skaer TL, et al. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med 1998;28:407–19
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Machlin SR, Zodet MW, et al. Health care for children and youth in the United States: 2001 annual report on access, utilization, quality, and expenditures. Ambul Pediatr 2002;2:419–37
   PubMedGoogle Scholar
• Vargas CM, Manski RJ. Dental expenditures and source of payment by race/ethnicity and other sociodemographic characteristics. J Public Health Dent 1999;59:33–8
   PubMed Web of Science ®Google Scholar
• Greene SB, Salber EJ. Racial differences in medical care expenditures. Med Care 1979;17:1029–36
   PubMed Web of Science ®Google Scholar
• Mullins CD, Shaya FT, Meng F, et al. Comparison of first refill rates among branded SSRI users. Clin Ther 2006;28:297–305
   PubMed Web of Science ®Google Scholar
• Mullins CD, Shaya FT, Meng F, et al. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy 2005;25:660–7
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Hur K, Bhaumick DK, et al. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005;62:165–72
   PubMed Web of Science ®Google Scholar
• Druss BG, Marcus SC, Olfson M, et al. Listening to generic Prozac: winners, losers, and sideliners. Health Aff 2004;23:210–6
   Web of Science ®Google Scholar
• Stagnitti MN, Pancholi M. Chronic conditions and outpatient prescription medicines for persons 18 and older in the U.S. civilian noninstitutionalized population, 1987 and 2001. Statistical Brief #58. December 2004. Agency for Healthcare Research and Quality, Rockville, MD. Available from http://%20www.meps.ahrq.gov/mepsweb/data_files/publications/st58/%20stat58.pdf [Last accessed 9 November 2006]
   Google Scholar
• Mendlewica J. Optimising antidepressant use in clinical practice: towards criteria for antidepressant selection. Br J Psychiatry Suppl 2001;42:S1–3
   PubMedGoogle Scholar